Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rheumatic Diseases | 26 | 2024 | 654 | 6.090 |
Why?
|
Nipecotic Acids | 3 | 2023 | 36 | 1.800 |
Why?
|
Giant Cell Arteritis | 4 | 2024 | 307 | 1.610 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 3 | 2023 | 225 | 1.370 |
Why?
|
Glucocorticoids | 7 | 2023 | 2159 | 1.270 |
Why?
|
Rheumatology | 8 | 2022 | 616 | 1.220 |
Why?
|
Antirheumatic Agents | 10 | 2024 | 1369 | 1.210 |
Why?
|
Autoimmune Diseases | 8 | 2024 | 2244 | 1.020 |
Why?
|
Aniline Compounds | 3 | 2023 | 1073 | 0.780 |
Why?
|
Lung Injury | 1 | 2022 | 422 | 0.590 |
Why?
|
Prednisone | 5 | 2023 | 1565 | 0.550 |
Why?
|
Arthritis, Rheumatoid | 7 | 2024 | 3753 | 0.490 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 3 | 2023 | 289 | 0.430 |
Why?
|
Biological Products | 2 | 2021 | 915 | 0.370 |
Why?
|
Gastric Antral Vascular Ectasia | 1 | 2020 | 6 | 0.360 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2021 | 131 | 0.330 |
Why?
|
Temporal Arteries | 1 | 2020 | 155 | 0.310 |
Why?
|
Hepatitis B virus | 2 | 2021 | 527 | 0.310 |
Why?
|
Myositis | 1 | 2021 | 270 | 0.300 |
Why?
|
Electronic Health Records | 1 | 2024 | 4822 | 0.270 |
Why?
|
Vasculitis | 1 | 2021 | 522 | 0.270 |
Why?
|
Scleroderma, Systemic | 1 | 2020 | 345 | 0.270 |
Why?
|
Arthritis, Infectious | 1 | 2020 | 347 | 0.260 |
Why?
|
Hepatitis B, Chronic | 1 | 2020 | 410 | 0.260 |
Why?
|
Respiration, Artificial | 3 | 2021 | 2631 | 0.240 |
Why?
|
Asthma | 1 | 2023 | 6230 | 0.230 |
Why?
|
Piperidines | 2 | 2021 | 1656 | 0.220 |
Why?
|
Humans | 48 | 2024 | 761208 | 0.210 |
Why?
|
Blister | 1 | 2023 | 86 | 0.210 |
Why?
|
Gout | 1 | 2020 | 621 | 0.210 |
Why?
|
Fever | 1 | 2020 | 1618 | 0.200 |
Why?
|
Middle Aged | 23 | 2024 | 220853 | 0.200 |
Why?
|
Remission Induction | 2 | 2022 | 2392 | 0.190 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1115 | 0.180 |
Why?
|
Comorbidity | 3 | 2024 | 10516 | 0.180 |
Why?
|
Hospitalization | 6 | 2021 | 10707 | 0.180 |
Why?
|
Lumbar Vertebrae | 1 | 2020 | 1876 | 0.180 |
Why?
|
Double-Blind Method | 3 | 2023 | 12341 | 0.180 |
Why?
|
Vaccination | 4 | 2024 | 3369 | 0.170 |
Why?
|
Male | 27 | 2024 | 360693 | 0.170 |
Why?
|
Pyrimidines | 2 | 2021 | 3027 | 0.170 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2022 | 2157 | 0.170 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 224 | 0.160 |
Why?
|
Immunity, Humoral | 1 | 2023 | 598 | 0.160 |
Why?
|
Female | 26 | 2024 | 392544 | 0.150 |
Why?
|
Physicians, Women | 1 | 2023 | 510 | 0.140 |
Why?
|
Referral and Consultation | 1 | 2020 | 3608 | 0.140 |
Why?
|
Antibody Formation | 2 | 2021 | 1391 | 0.130 |
Why?
|
Cohort Studies | 5 | 2024 | 41496 | 0.130 |
Why?
|
Hepatitis B | 1 | 2021 | 703 | 0.130 |
Why?
|
Immunosuppressive Agents | 2 | 2022 | 4190 | 0.120 |
Why?
|
Psoriasis | 1 | 2021 | 946 | 0.110 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3093 | 0.100 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3215 | 0.100 |
Why?
|
Antibodies, Viral | 3 | 2024 | 3149 | 0.090 |
Why?
|
Risk Factors | 4 | 2024 | 74239 | 0.090 |
Why?
|
Glucose | 1 | 2023 | 4342 | 0.090 |
Why?
|
Premature Birth | 1 | 2023 | 1784 | 0.090 |
Why?
|
Churg-Strauss Syndrome | 1 | 2021 | 75 | 0.090 |
Why?
|
RNA Polymerase III | 1 | 2020 | 57 | 0.090 |
Why?
|
Aged | 10 | 2024 | 169288 | 0.090 |
Why?
|
Antibodies, Antinuclear | 1 | 2020 | 342 | 0.080 |
Why?
|
Electronics | 1 | 2020 | 317 | 0.080 |
Why?
|
Disease Progression | 2 | 2022 | 13511 | 0.080 |
Why?
|
Registries | 4 | 2022 | 8247 | 0.080 |
Why?
|
Gout Suppressants | 1 | 2020 | 177 | 0.080 |
Why?
|
Confusion | 1 | 2020 | 278 | 0.070 |
Why?
|
Massachusetts | 2 | 2020 | 8837 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2024 | 9187 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2421 | 0.070 |
Why?
|
Adult | 10 | 2024 | 221119 | 0.060 |
Why?
|
Physicians | 1 | 2023 | 4584 | 0.060 |
Why?
|
Goals | 1 | 2020 | 710 | 0.060 |
Why?
|
China | 1 | 2020 | 2374 | 0.060 |
Why?
|
Workload | 1 | 2020 | 845 | 0.060 |
Why?
|
Uric Acid | 1 | 2020 | 807 | 0.060 |
Why?
|
Arthroscopy | 1 | 2020 | 969 | 0.050 |
Why?
|
Internship and Residency | 1 | 2023 | 5885 | 0.050 |
Why?
|
Endemic Diseases | 1 | 2023 | 191 | 0.050 |
Why?
|
Interpersonal Relations | 1 | 2020 | 1437 | 0.050 |
Why?
|
Burnout, Professional | 1 | 2020 | 703 | 0.050 |
Why?
|
Clinical Competence | 2 | 2023 | 4788 | 0.050 |
Why?
|
Treatment Outcome | 2 | 2023 | 64681 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2024 | 80674 | 0.040 |
Why?
|
Intubation | 1 | 2020 | 139 | 0.040 |
Why?
|
Respiratory Therapy | 1 | 2020 | 125 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2023 | 537 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 612 | 0.040 |
Why?
|
Odds Ratio | 1 | 2021 | 9652 | 0.040 |
Why?
|
Inpatients | 1 | 2020 | 2545 | 0.040 |
Why?
|
Biopsy | 1 | 2020 | 6781 | 0.040 |
Why?
|
Methotrexate | 1 | 2023 | 1718 | 0.030 |
Why?
|
Pilot Projects | 1 | 2020 | 8642 | 0.030 |
Why?
|
Pregnant Women | 1 | 2021 | 568 | 0.030 |
Why?
|
Pandemics | 2 | 2021 | 8663 | 0.030 |
Why?
|
Canada | 1 | 2021 | 2125 | 0.030 |
Why?
|
Internal Medicine | 1 | 2023 | 1050 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26071 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2022 | 58952 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14675 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2024 | 1589 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12976 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2643 | 0.030 |
Why?
|
Young Adult | 3 | 2021 | 59221 | 0.030 |
Why?
|
Neurology | 1 | 2022 | 784 | 0.030 |
Why?
|
United States | 3 | 2023 | 72339 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2022 | 15841 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2023 | 26199 | 0.020 |
Why?
|
Incidence | 1 | 2020 | 21365 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6304 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7407 | 0.020 |
Why?
|
Pregnancy | 2 | 2023 | 29893 | 0.020 |
Why?
|
Quality of Life | 1 | 2021 | 13367 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54435 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 12747 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9327 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 22174 | 0.020 |
Why?
|
Adolescent | 1 | 2021 | 88298 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36415 | 0.010 |
Why?
|
Child | 1 | 2023 | 80152 | 0.010 |
Why?
|
Concepts
(120)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(59)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_